AbbVie (ABBV) with shares pulling back to the 55-EMA last week and basing in a multi-day range, relative strength over the last six months and one of the better-looking overall charts right now. The 8- and 21-EMA are remittance above but through 160.50 sets up for a nice move back near $175.